2,7b-Diazabenzo[f]cycloprop[cd]indene-4,7-dione, 3-[[(aminocarbonyl)oxy]methyl]-1,2,2a,3,7c,7d-hexahydro-2a,5-dimethoxy-6-methyl-, (2aR,3S,7cS,7dS)- (9CI);Isomitomycin A
Isomitomycin A is a potential SARS-CoV-2 inhibitor that targets the SARS-CoV-2 spike glycoprotein mimicking the hACE2 binding site; it can be used in research on COVID-19.